BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND SUFU, RP11-47A8_1, 51684, ENSG00000121410, PRO1280, SUFUXL, Q9UMX1, SUFUH AND Prognosis
7577 results:

  • 1. [Expression of CD30 in Patients with Diffuse Large B-Cell lymphoma and Clinical Significance].
    Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and prognosis of Non-Hodgkin's lymphoma].
    Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [A Real-World Single-Center Study of Adult Hodgkin's lymphoma].
    Wang LL; Tian L; Dong F; Yang P; Wan W; Li QH; Ma L; Gao JJ; Wang JJ; Zhao W; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):428-433. PubMed ID: 38660847
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
    Hu Y; Zhang M; Yang T; Mo Z; Wei G; Jing R; Zhao H; Chen R; Zu C; Gu T; Xiao P; Hong R; Feng J; Fu S; Kong D; Xu H; Cui J; Huang S; Liang B; Yuan X; Cui Q; Guo H; Yu Y; Feng Y; Jin C; Ren J; Chang AH; Wang D; Huang H
    N Engl J Med; 2024 Apr; 390(16):1467-1480. PubMed ID: 38657244
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways.
    Chakravarti N; Boles A; Burzinski R; Sindaco P; Isabelle C; McConnell K; Mishra A; Porcu P
    Sci Rep; 2024 Apr; 14(1):9305. PubMed ID: 38653804
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Specific mortality in patients with diffuse large B-cell lymphoma: a retrospective analysis based on the surveillance, epidemiology, and end results database.
    Xu H; Yan R; Ye C; Li J; Ji G
    Eur J Med Res; 2024 Apr; 29(1):241. PubMed ID: 38643217
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1.
    Giardino G; Lanni V; Mascolo M; Russo D; Cirillo E; Romano R; Cillo F; Grilli L; Prencipe MR; Iuliano A; Uccello G; De Fusco C; Menna G; Scalia G; Portella G; Pignata C
    Front Immunol; 2024; 15():1370991. PubMed ID: 38633254
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Efficacy and safety analysis of P-GemDOx regimen and stratified prognosis in patients with early extranodal NK/T cell lymphoma].
    Xing TY; Wang WT; Shen HR; Wu JZ; Yin H; Li Y; Wang L; Liang JH; Li JY; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):163-169. PubMed ID: 38604793
    [No Abstract]    [Full Text] [Related]  

  • 9. Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions.
    Deng H; Han Y; Liu L; Zhang H; Liu D; Wen J; Huang M; Zhao L
    J Med Chem; 2024 Apr; 67(8):5963-5998. PubMed ID: 38597264
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
    Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.
    Draye-Carbonnier S; Camus V; Becker S; Tonnelet D; Lévêque E; Zduniak A; Jardin F; Tilly H; Vera P; Decazes P
    Sci Rep; 2024 Apr; 14(1):8033. PubMed ID: 38580734
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies.
    Giudice V; Ianniello M; De Novellis D; Pezzullo L; Petrillo N; Serio B; D'Addona M; Della Corte AM; Rizzo M; Cuffa B; Castaldi MA; Savarese P; Mori A; Castiello R; Fico A; Savarese G; Selleri C
    Clin Exp Med; 2024 Apr; 24(1):69. PubMed ID: 38578383
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
    Li J; Ma X; Xu F; Yan Y; Chen W
    Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical features of intussusception in children secondary to small bowel tumours: a retrospective study of 31 cases.
    Wang L; Zhang H; Wang D; Shen Q; Huang L; Liu T
    BMC Pediatr; 2024 Apr; 24(1):227. PubMed ID: 38561715
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical and histopathological spectrum of cranial small round cell tumors: An experience from a tertiary care center.
    Gupta P; Siraj F; Shankar KB; Rawat M; Mankotia DS; Yadav V; Dagar A
    J Cancer Res Ther; 2024 Jan; 20(1):238-242. PubMed ID: 38554327
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.
    Nakamura T; Tatetsu H; Higuchi Y; Endo S; Shiraishi S; Kawanaka K; Imakane D; Sonoda M; Furuta R; Shichijo T; Honda Y; Karube K; Mikami Y; Nosaka K; Matsuoka M; Yasunaga JI
    J Clin Exp Hematop; 2024; 64(1):45-51. PubMed ID: 38538318
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome.
    Panagopoulos I; Andersen K; Wik HS; Tandsæther MR
    Anticancer Res; 2024 Apr; 44(4):1389-1397. PubMed ID: 38537997
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell lymphoma.
    Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
    Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Progress in treatment of primary mediastinal large B-cell lymphoma].
    Chen LW; Li JY; Fan L
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):98-102. PubMed ID: 38527847
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 379.